Globus Medical Reports Second Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Globus Medical (GMED) PT Raised to $100 at Northland Capital Markets
August 5, 2021 7:36 AM EDTNorthland Capital Markets analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 while maintaining an Outperform rating.
The analyst commented, "GMED reported record revenues in 2Q21 of $251.0 million, up 68.6% y/y (up 67.9% cc y/y), easily beating consensus of... More
